Search results for the

How to inform us of changes or developments, and what to consider when you do. 

Recordings of our webinars on record-keeping.

This policy statement sets out our broad approach to developing memorandums of understanding (MoUs) with other organisations.

We are concerned to hear that people with Type 2 diabetes are experiencing problems accessing GLP-1 receptor agonists (GLP-1 RAs).

This year, we launched a new Corporate Strategy and a commitment to meet our values to be fair, compassionate, inclusive and enterprising.

We will be asking you to ask you to complete an equality monitoring form to help us make sure our services are accessible to everyone

We are consulting on changes to our standards for prescribing until Friday 4 January 2019 and we are keen to hear your views

We recognise that, due to unavoidable circumstances, some registrants may need to defer (put off) their audit.